23729
Tedizolid Phosphate
Cayman Chemical
DESCRIPTION
A prodrug form of tedizolid; reduces vegetation titer in a rabbit model of aortic valve endocarditis caused by MRSA (15 mg/kg); reduces densities of methicillin-susceptible S. aureus and MRSA infection in a mouse model of catheter-related biofilm infection; increases survival in a rabbit model of MRSA necrotizing pneumonia
DETAILS
- Inchi: InChI=1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1
- Purity: ≥98%
- Raptas: Product Type|Biochemicals|Antibiotics|Oxazolidinones||Research Area|Cardiovascular System|Heart||Research Area|Cardiovascular System|Vasculature||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|MRSA||Research Area|Infectious Disease|Bacterial Diseases|Pneumonia
- Smiles: FC1=C(C2=CN=C(C3=NN(C)N=N3)C=C2)C=CC(N4C(O[C@@H](COP(O)(O)=O)C4)=O)=C1
- Inchikey: QCGUSIANLFXSGE-GFCCVEGCSA-N
- Cas Number: 856867-55-5
- Formulation: A crystalline solid
- Storage Temp: -20
- Shipping Temp: -20
- Formula Markup: C17H16FN6O6P
- Formula Weight: 450.3
- Shelf Life Days: 730